Na. Calcutt et al., ALDOSE REDUCTASE INHIBITION, DOPPLER FLUX AND CONDUCTION IN DIABETIC RAT NERVE, European journal of pharmacology, 251(1), 1994, pp. 27-33
Two chemically distinct aldose reductase inhibitors, ponalrestat and t
olrestat, were tested against laser Doppler blood flow and conduction
deficits in the sciatic nerve of diabetic rats. The effects of two mon
ths of streptozotocin-induced diabetes and aldose reductase inhibition
on body weight, plasma glucose, and nerve sugars and polyols were com
parable to those reported previously. Nerve blood flow, reflected by l
aser Doppler flow measurements, and motor nerve conduction velocity we
re both significantly less in diabetic than in control animals. Both o
f these reductions were prevented by ponalrestat, but not tolrestat. T
hus, either deficits in laser Doppler blood flow and conduction are no
t aldose reductase inhibitor-dependent or tolrestat has some other pro
perty which offsets the beneficial effects of aldose reductase inhibit
ion. In either case, these data are consistent with the hypothesis tha
t reduced nerve blood flow contributes to conduction deficits in diabe
tes.